as I've mentioned in another post, the investor experience can be considerably improved if one buys during times of DISCOUNT to NTA rather than when trading at NTA or at premium. As shown in the monthly reports, AFI's share price relative to NTA swings up and down, and not long ago was trading at 10%+ premium to NTA. It is currently at an unheard of 9% discount to NTA, arguably a great time to buy.
LICs are able to smoothen their dividend payments by retaining some profits, thus during the GFC for example AFI did not lower it's dividend unlike the majority of other companies trading on the ASX, which appeals to some income investors. They are also very simple at income tax time, with only dividends and franking credits unlike the complex AMIT forms put out by managed funds and some ETFs which can contain a plethora of data such as unfranked distributions, realised capital gains for the past 12 months ( which the investor is liable for at tax time, even if they bought the fund only a few days or weeks before June 30......such a pain ! ), foreign income etc.
Each to their own, but I think that LICs, ETFs, unlisted managed funds, and direct shares all have a valid role in a diversified portfolio.
I can guarantee you that many of us holders are a lot younger than 80.
Index ETFs are not new, they have been around for many years yet AFI continues to trade in some years at a premium, other years at a discount.
- Forums
- ASX - By Stock
- AFI
- what am I missing?
AFI
australian foundation investment company limited
Add to My Watchlist
0.41%
!
$7.37

what am I missing?, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.37 |
Change
0.030(0.41%) |
Mkt cap ! $9.242B |
Open | High | Low | Value | Volume |
$7.34 | $7.40 | $7.33 | $4.616M | 626.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 408 | $7.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.37 | 7880 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 408 | 7.360 |
2 | 13490 | 7.350 |
5 | 20000 | 7.340 |
5 | 26197 | 7.330 |
3 | 13393 | 7.320 |
Price($) | Vol. | No. |
---|---|---|
7.370 | 7880 | 4 |
7.380 | 5188 | 1 |
7.390 | 1500 | 1 |
7.400 | 61162 | 19 |
7.410 | 10154 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AFI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online